Item 5.07 Submission of Matters to a Vote of Security Holders.

AbbVie Inc. ("AbbVie") held its Annual Meeting of Stockholders on May 7, 2021. The following is a summary of the matters voted on at that meeting.





  (1)    The stockholders elected AbbVie's Class III Directors with terms expiring
         in 2024, as follows:




Name                  For             Against       Broker Non-Votes

Roxanne S. Austin 1,176,814,309 40,193,567 266,940,608 Richard A. Gonzalez 1,143,418,886 73,588,990 266,940,608 Rebecca B. Roberts 1,178,818,824 38,189,052 266,940,608 Glenn F. Tilton 1,092,161,771 124,846,105 266,940,608






  (2)    The stockholders ratified the appointment of Ernst & Young LLP as
         AbbVie's independent registered public accounting firm for 2021, as
         follows:




For             Against      Abstain
1,443,141,768   38,474,335   2,332,381




  (3)    The stockholders approved, on an advisory basis, the compensation of
         AbbVie's named executive officers listed in the proxy statement for the
         2021 annual meeting, as follows:




For             Against       Abstain     Broker Non-Votes
1,088,078,054   122,760,887   6,168,935   266,940,608




  (4)    The stockholders approved the Amended and Restated 2013 Incentive Stock
         Program, as follows:




For             Against      Abstain     Broker Non-Votes
1,151,977,015   60,300,643   4,730,218   266,940,608




  (5)    The stockholders approved the Amended and Restated 2013 Employee Stock
         Purchase Plan for Non-U.S. Employees, as follows:




For             Against      Abstain     Broker Non-Votes
1,179,691,622   33,184,479   4,131,775   266,940,608




  (6)    The stockholders did not approve the management proposal regarding
         amendment of the certificate of incorporation to eliminate supermajority
         voting, as follows:




For             Against      Abstain     Broker Non-Votes
1,200,648,034   12,015,517   4,344,325   266,940,608




  (7)    The stockholders did not approve a stockholder proposal to issue a
         lobbying report, as follows:




For           Against       Abstain      Broker Non-Votes
435,784,510   770,846,870   10,376,496   266,940,608




  (8)    The stockholders did not approve a stockholder proposal to adopt a policy
         to require an independent chair, as follows:




For           Against       Abstain      Broker Non-Votes

330,233,388 831,267,134 55,507,354 266,940,608

© Edgar Online, source Glimpses